In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe-Reference-Cited by-同舟云学术

In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe

Published:2002-04 Issue:4 Volume:8 Page:214-221
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Critchley I.A.,Jones M.E.,Heinze P.D.,Hubbard D.,Engler H.D.,Evangelista A.T.,Thornsberry C.,Karlowsky J.A.,Sahm D.F.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference40 articles.

1. Treatment of pneumonia: new strategies for changing pathogens;Ashby;Clin Ther,1991

2. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia;Ruiz-Gonzalez;Am J Med,1999

3. Importance of atypical pathogens of community-acquired pneumonia;Plouffe;Clin Infect Dis,2000

4. Ofloxacin versus standard therapy in the treatment of community-acquired pneumonia requiring hospitalization;Plouffe;Antimicrob Agents Chemother,1996

5. Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis;Sahm;Antimicrob Agents Chemother,2001

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in polymeric and non-polymeric nanocarriers for the magnified delivery of levofloxacin against bacterial infection;Journal of Nanoparticle Research;2024-08

2. Severe problem of macrolides resistance to common pathogens in China;Frontiers in Cellular and Infection Microbiology;2023-08-10

3. Mycoplasma pneumoniae – modern data on the structure, molecular biology and epidemiology of the pathogen;Clinical Microbiology and Antimicrobial Chemotherapy;2023

4. Global prevalence of resistance to macrolides in Mycoplasma pneumoniae: a systematic review and meta-analysis;Journal of Antimicrobial Chemotherapy;2022-06-09

5. Neuroprotective effects of some epigenetic modifying drugs’ on Chlamydia pneumoniae-induced neuroinflammation: A novel model;PLOS ONE;2021-11-30